Relative bioavailability of trimeprazine tablets investigated in man using HPLC with electrochemical detection

Oliver Y.‐P Hu, Edward Gfeller, John H. Perrin, Stephen H. Curry

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The stability, partition coefficient, plasma protein binding, red blood cell distribution, and whole blood concentrations of trimeprazine were investigated. Trimeprazine solution was stable for 6 months at −20 °C and 3.5 months at 40 °C. In whole blood trimeprazine was stable for 5 weeks at −20 °C., 24 h at 4 °C., 4h at 25 °C and 1 h at 37 °C. The apparent hexane‐water partition coefficient varied from 1.50 (at pH 4.83) to over 100 (at pH 10.54). The fraction bound to plasmaprotein exceeded 0.9 as estimated by equilibrium dialysis with correction for volume shift. The mean plasma/red blood cell concentration ratio was 1.17 and the mean red blood cell/plasma distribution coefficient was 8.65. Six healthy adult males received single 5 mg doses of trimeprazine in a syrup (5 mg in 10 ml) and tablets with at least two weeks between doses. Blood was collected for 48 h. The mean (±s.e.m.) times for peak blood concentrations were 3.5 ± 0.22 h for the syrup and 4.5 ± 0.43 h for the tablets. There were no significant differences in Cmax values. The overall mean (±s.e.m.) terminal phase half‐life was 4.78 ± 0.59 h. Mean (±s.e.m.) areas under the concentration time curves from 0 to infinity (AUC) were 11.0 ± 1.99 ng h−1 ml−1 and 7.67 ± 1.05 ng h−1 ml−1 for syrup and tablets, respectively. The mean relative bioavailability for the tablets was approximately 70% with respect to the syrup.

Original languageEnglish
Pages (from-to)172-176
Number of pages5
JournalJournal of Pharmacy and Pharmacology
Volume38
Issue number3
DOIs
Publication statusPublished - Jan 1 1986
Externally publishedYes

Fingerprint

Trimeprazine
Biological Availability
Tablets
High Pressure Liquid Chromatography
Erythrocytes
Protein Binding
Area Under Curve
Half-Life
Blood Proteins
Dialysis

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Cite this

Relative bioavailability of trimeprazine tablets investigated in man using HPLC with electrochemical detection. / Hu, Oliver Y.‐P; Gfeller, Edward; Perrin, John H.; Curry, Stephen H.

In: Journal of Pharmacy and Pharmacology, Vol. 38, No. 3, 01.01.1986, p. 172-176.

Research output: Contribution to journalArticle

Hu, Oliver Y.‐P ; Gfeller, Edward ; Perrin, John H. ; Curry, Stephen H. / Relative bioavailability of trimeprazine tablets investigated in man using HPLC with electrochemical detection. In: Journal of Pharmacy and Pharmacology. 1986 ; Vol. 38, No. 3. pp. 172-176.
@article{dba92109b9db4601a03f130c701bfac5,
title = "Relative bioavailability of trimeprazine tablets investigated in man using HPLC with electrochemical detection",
abstract = "The stability, partition coefficient, plasma protein binding, red blood cell distribution, and whole blood concentrations of trimeprazine were investigated. Trimeprazine solution was stable for 6 months at −20 °C and 3.5 months at 40 °C. In whole blood trimeprazine was stable for 5 weeks at −20 °C., 24 h at 4 °C., 4h at 25 °C and 1 h at 37 °C. The apparent hexane‐water partition coefficient varied from 1.50 (at pH 4.83) to over 100 (at pH 10.54). The fraction bound to plasmaprotein exceeded 0.9 as estimated by equilibrium dialysis with correction for volume shift. The mean plasma/red blood cell concentration ratio was 1.17 and the mean red blood cell/plasma distribution coefficient was 8.65. Six healthy adult males received single 5 mg doses of trimeprazine in a syrup (5 mg in 10 ml) and tablets with at least two weeks between doses. Blood was collected for 48 h. The mean (±s.e.m.) times for peak blood concentrations were 3.5 ± 0.22 h for the syrup and 4.5 ± 0.43 h for the tablets. There were no significant differences in Cmax values. The overall mean (±s.e.m.) terminal phase half‐life was 4.78 ± 0.59 h. Mean (±s.e.m.) areas under the concentration time curves from 0 to infinity (AUC∞) were 11.0 ± 1.99 ng h−1 ml−1 and 7.67 ± 1.05 ng h−1 ml−1 for syrup and tablets, respectively. The mean relative bioavailability for the tablets was approximately 70{\%} with respect to the syrup.",
author = "Hu, {Oliver Y.‐P} and Edward Gfeller and Perrin, {John H.} and Curry, {Stephen H.}",
year = "1986",
month = "1",
day = "1",
doi = "10.1111/j.2042-7158.1986.tb04539.x",
language = "English",
volume = "38",
pages = "172--176",
journal = "Journal of Pharmacy and Pharmacology",
issn = "0022-3573",
publisher = "Pharmaceutical Press",
number = "3",

}

TY - JOUR

T1 - Relative bioavailability of trimeprazine tablets investigated in man using HPLC with electrochemical detection

AU - Hu, Oliver Y.‐P

AU - Gfeller, Edward

AU - Perrin, John H.

AU - Curry, Stephen H.

PY - 1986/1/1

Y1 - 1986/1/1

N2 - The stability, partition coefficient, plasma protein binding, red blood cell distribution, and whole blood concentrations of trimeprazine were investigated. Trimeprazine solution was stable for 6 months at −20 °C and 3.5 months at 40 °C. In whole blood trimeprazine was stable for 5 weeks at −20 °C., 24 h at 4 °C., 4h at 25 °C and 1 h at 37 °C. The apparent hexane‐water partition coefficient varied from 1.50 (at pH 4.83) to over 100 (at pH 10.54). The fraction bound to plasmaprotein exceeded 0.9 as estimated by equilibrium dialysis with correction for volume shift. The mean plasma/red blood cell concentration ratio was 1.17 and the mean red blood cell/plasma distribution coefficient was 8.65. Six healthy adult males received single 5 mg doses of trimeprazine in a syrup (5 mg in 10 ml) and tablets with at least two weeks between doses. Blood was collected for 48 h. The mean (±s.e.m.) times for peak blood concentrations were 3.5 ± 0.22 h for the syrup and 4.5 ± 0.43 h for the tablets. There were no significant differences in Cmax values. The overall mean (±s.e.m.) terminal phase half‐life was 4.78 ± 0.59 h. Mean (±s.e.m.) areas under the concentration time curves from 0 to infinity (AUC∞) were 11.0 ± 1.99 ng h−1 ml−1 and 7.67 ± 1.05 ng h−1 ml−1 for syrup and tablets, respectively. The mean relative bioavailability for the tablets was approximately 70% with respect to the syrup.

AB - The stability, partition coefficient, plasma protein binding, red blood cell distribution, and whole blood concentrations of trimeprazine were investigated. Trimeprazine solution was stable for 6 months at −20 °C and 3.5 months at 40 °C. In whole blood trimeprazine was stable for 5 weeks at −20 °C., 24 h at 4 °C., 4h at 25 °C and 1 h at 37 °C. The apparent hexane‐water partition coefficient varied from 1.50 (at pH 4.83) to over 100 (at pH 10.54). The fraction bound to plasmaprotein exceeded 0.9 as estimated by equilibrium dialysis with correction for volume shift. The mean plasma/red blood cell concentration ratio was 1.17 and the mean red blood cell/plasma distribution coefficient was 8.65. Six healthy adult males received single 5 mg doses of trimeprazine in a syrup (5 mg in 10 ml) and tablets with at least two weeks between doses. Blood was collected for 48 h. The mean (±s.e.m.) times for peak blood concentrations were 3.5 ± 0.22 h for the syrup and 4.5 ± 0.43 h for the tablets. There were no significant differences in Cmax values. The overall mean (±s.e.m.) terminal phase half‐life was 4.78 ± 0.59 h. Mean (±s.e.m.) areas under the concentration time curves from 0 to infinity (AUC∞) were 11.0 ± 1.99 ng h−1 ml−1 and 7.67 ± 1.05 ng h−1 ml−1 for syrup and tablets, respectively. The mean relative bioavailability for the tablets was approximately 70% with respect to the syrup.

UR - http://www.scopus.com/inward/record.url?scp=0022607132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022607132&partnerID=8YFLogxK

U2 - 10.1111/j.2042-7158.1986.tb04539.x

DO - 10.1111/j.2042-7158.1986.tb04539.x

M3 - Article

VL - 38

SP - 172

EP - 176

JO - Journal of Pharmacy and Pharmacology

JF - Journal of Pharmacy and Pharmacology

SN - 0022-3573

IS - 3

ER -